Видео ютуба по тегу Vegf Inhibitor

VEGF-Ax as a Cancer Inhibitor
VEGF-Ax as a Cancer Inhibitor
Investigating the Role of VEGF in Targeted Therapy for Cancer
Investigating the Role of VEGF in Targeted Therapy for Cancer
Long-term studies of VEGF inhibitor use
Long-term studies of VEGF inhibitor use
Toxicities Associated With VEGF TKIs and Checkpoint Inhibitors in mRCC
Toxicities Associated With VEGF TKIs and Checkpoint Inhibitors in mRCC
Part 2: Long-term studies of VEGF inhibitor use
Part 2: Long-term studies of VEGF inhibitor use
The Current State of Research on Long-term VEGF Inhibitor Use
The Current State of Research on Long-term VEGF Inhibitor Use
Use of VEGF-Targeted Tyrosine Kinase Inhibitors
Use of VEGF-Targeted Tyrosine Kinase Inhibitors
IO-IO vs. IO-VEGF inhibitor therapy for mRCC
IO-IO vs. IO-VEGF inhibitor therapy for mRCC
Combining EGFR and VEGF inhibitors for NSCLC
Combining EGFR and VEGF inhibitors for NSCLC
Therapeutic applications of VEGF inhibitors - Napoleone Ferrara, MD - 10th APSA Annual Meeting
Therapeutic applications of VEGF inhibitors - Napoleone Ferrara, MD - 10th APSA Annual Meeting
Dr. Sonpavde on Combining VEGF/PD-1 Inhibitors in Metastatic Urothelial Carcinoma
Dr. Sonpavde on Combining VEGF/PD-1 Inhibitors in Metastatic Urothelial Carcinoma
Dr. Gupta on VEGF Inhibitors Combined with Immunotherapy in Kidney Cancer
Dr. Gupta on VEGF Inhibitors Combined with Immunotherapy in Kidney Cancer
Dr. McDermott on VEGF/PD-1 Inhibition in RCC
Dr. McDermott on VEGF/PD-1 Inhibition in RCC
Combined blockade of VEGF and PD-1 signaling in RCC
Combined blockade of VEGF and PD-1 signaling in RCC
VEGF Inhibition in NSCLC
VEGF Inhibition in NSCLC
Role of the VEGF Inhibitor Aflibercept in Metastatic Colorectal Cancer
Role of the VEGF Inhibitor Aflibercept in Metastatic Colorectal Cancer
VEGF and PD-1 Inhibition in Advanced Gastric/GEJ Cancer
VEGF and PD-1 Inhibition in Advanced Gastric/GEJ Cancer
Combined inhibition of PARP and VEGF in gastric cancer
Combined inhibition of PARP and VEGF in gastric cancer
Dr. Messersmith on the Need for Biomarkers to Distinguish Between VEGF Inhibitors in CRC
Dr. Messersmith on the Need for Biomarkers to Distinguish Between VEGF Inhibitors in CRC
Episode 375: Pharmacology 101: VEGF Inhibitors
Episode 375: Pharmacology 101: VEGF Inhibitors
Evaluating the future role of VEGF inhibitors in pancreatic cancer
Evaluating the future role of VEGF inhibitors in pancreatic cancer
Combining immunotherapy with VEGF inhibitors to treat kidney cancer
Combining immunotherapy with VEGF inhibitors to treat kidney cancer
2. Beyond VEGF: Role of Ang-2 in Retinal Vascular Pathology
2. Beyond VEGF: Role of Ang-2 in Retinal Vascular Pathology
Vascular Endothelial Growth Factor (VEGF)
Vascular Endothelial Growth Factor (VEGF)
Current status of VEGF inhibitor/immunotherapy combinations in RCC
Current status of VEGF inhibitor/immunotherapy combinations in RCC